Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > PP Closed

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Sep 11, 2023 10:02am

209 Views

Post# 35629197

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:PP Closed

Although for it may be true that only 1 in one thousand biotechnology companies achieve BTD approval, I don't think that is an accurate way of calculating the odds for TLT. I think a better way of calculating the odds for TLT would be to ask "what are the odds of a biotechnology company that has already achieved fast track status then receiving breakthrough designation". I don't know what that number is, however I willi g to bet it is better than one in a thousand.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?